Breeze Meds review

Breeze Meds charges $199 a month for compounded semaglutide and $299 for compounded tirzepatide, month to month, with nothing billed until a provider approves you. The counter-intuitive part is the prepay ladder: its 3- and 6-month bundles cost more per month than simply paying monthly.

Run the semaglutide numbers. Month to month is $199. The 3-month bundle is $748, which is $249.33 a month. The 6-month is $1,248, or $208 a month. Only the 12-month at $2,298 comes in under the monthly rate, at $191.50, and that is a single charge of $2,298 for a medication you may not tolerate past week six. Tirzepatide behaves the same way: $299 month to month, $1,068 for three months ($356 a month), $1,918 for six ($319.67), and $3,498 for twelve ($291.50). Unless you are prepaying an entire year, the monthly plan is the cheaper plan on both molecules.

The oral dissolving tablets are a separate line: $299 a month for oral semaglutide and $399 for oral tirzepatide. Their bundles barely move at all. Oral semaglutide is $899 for three months and $1,799 for six, which is $299.67 and $299.83 a month, effectively the same rate you would pay without committing to anything. That puts a needle-free semaglutide at the same monthly cost as an injectable tirzepatide, which is the real trade a reader who dislikes needles is being asked to make here.

It is worth seeing what the year-long commitment actually buys. Twelve months of semaglutide at the monthly rate is $2,388; the 12-month prepay is $2,298, so a full year decided in advance saves $90. On tirzepatide the gap is identical, $3,588 paid monthly against $3,498 up front, again $90. That is the entire discount for handing over a year of payments before a first dose, and it is worth weighing against the fact that a meaningful share of people stop a GLP-1 within the first few months for reasons of tolerance or effect.

Watch which number you are reading on breezemeds.com. The product cards on the homepage advertise injectable tirzepatide at "Starting at $399" and semaglutide at $199, but $399 is the struck-through list price, not the live rate. The checkout catalog charges $299 for the same injectable tirzepatide. That gap is why the tirzepatide figure here carries "(list $399)" beside it: the marketing card and the checkout disagree, and $299 is the one attached to a plan that actually bills.

Every published figure is quoted at the lowest dose, and the intake itself says higher doses may cost more. None of these numbers is a rate you can budget a titration against, which is the single biggest caveat on the price. There is also no pricing page to check: /pricing, /products, /get-started and /weight-loss all return a not-found page as of 2026-08-28. The prices live in the file the checkout loads, so a visitor sees them only after starting the questionnaire, which opens by asking about weight-loss goals rather than showing a cost.

The fee structure around the medication is unusually clean otherwise. One price covers the consult, the medication, supplies, shipping and support, the consult is free if you go ahead, and you can cancel or change plans at any time. The one charge to know about is the $80 consultation fee that applies if a provider approves you and you then decline. Its FAQ answers the coverage question directly, "We service all 50 states," and the company is LegitScript-certified. Everything is compounded, so there is no brand Wegovy or Zepbound lane, and no lab or monitoring program is published.

This works for someone starting at a low dose who wants to pay as they go and dislikes committing money before a clinician has said yes. It works badly for anyone who needs to know what month six costs at a higher dose, or who wants brand Wegovy or Zepbound. And if a bundle is being pitched to you as the saving, check the arithmetic above first, because on both molecules the 3- and 6-month options are the expensive way to buy.